AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹785 Cr | ₹792 Cr | ₹562 Cr | ₹576 Cr | ₹457 Cr |
What is the latest Cash Flow from Operating Activities ratio of AJANTA PHARMA ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹785 Cr |
Mar2023 | ₹792 Cr |
Mar2022 | ₹562 Cr |
Mar2021 | ₹576 Cr |
Mar2020 | ₹457 Cr |
How is Cash Flow from Operating Activities of AJANTA PHARMA Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹785 Cr | -0.89 | |
Mar2023 | ₹792 Cr | 41.02 | |
Mar2022 | ₹562 Cr | -2.53 | |
Mar2021 | ₹576 Cr | 26.17 | |
Mar2020 | ₹457 Cr | - |
Compare Cash Flow from Operating Activities of peers of AJANTA PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AJANTA PHARMA | ₹33,951.6 Cr | 5.7% | -5.3% | 24.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,132.0 Cr | 2.2% | -5.8% | 22.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,254.0 Cr | 4.1% | -7% | 52% | Stock Analytics | |
CIPLA | ₹116,123.0 Cr | 1.3% | -4.8% | 9.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,573.0 Cr | 2.2% | -10.9% | -0.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,966.9 Cr | 7% | -0.2% | 27.5% | Stock Analytics |
AJANTA PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AJANTA PHARMA | 5.7% |
-5.3% |
24.4% |
SENSEX | 2.8% |
-3.1% |
9% |
You may also like the below Video Courses